Shares of Coca-Cola Co. and PepsiCo Inc. were slammed on Thursday, after Walmart Inc.’s U.S. chief executive said the new class of weight-loss drugs like Ozempic and Wegovy were causing customers to buy fewer groceries and cut back on those that are high in calories.
The comments sent Coca-Cola’s shares KO, -4.83% down 4.8% and PepsiCo’s shares PEP, -5.22% down 5.2%. Both were slightly higher early Friday. In August, Morgan Stanley analysts wrote that packaged-food and beverage makers, restaurants, grocery stores and weight-loss programs would all be affected as the pool of patients is expected to grow to 24 million people, or nearly 7% of the overall U.S. population in the next decade.Read now: As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
The new class of medicines includes Novo Nordisk’s NOVO.B, +0.93% NVO, +1.07% Wegovy and Ozempic and Eli Lilly’s LLY, +1.89% Mounjaro. They’ve become so popular in the U.S. that supplies have at times run short and the U.S. Food and Drug Administration has been forced to warn patients against using knockoff versions.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: MarketWatch - 🏆 3. / 97 Lire la suite »
La source: wwd - 🏆 24. / 68 Lire la suite »